Search company, investor...

Veon

Stage

Acquired | Acquired

Total Raised

$13.5M

About Veon

Veon is a provider of clickable, interactive streaming video. Veon also provides a platform to enable advertisers, content developers and service providers to transform existing, one-dimensional Internet content into rich multimedia experiences.

Headquarters Location

Herzliya,

Israel

Missing: Veon's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Veon's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest Veon News

Why Lufax Holding Shares Are Trading Lower By Over 11%; Here Are 21 Stocks Moving Premarket - Conformis (

Nov 25, 2022

Gainers VEON Ltd. VEON shares rose 31.1% to $0.6095 in pre-market trading after the company agreed to sell its Russian business, Vimpelcom for 130 billion roubles ($2.2 billion). Cosmos Holdings Inc. COSM rose 26.8% to $0.4058 in pre-market trading. Cosmos Holdings recently posted a Q3 loss of $0.08 per share. JE Cleantech Holdings Limited JCSE rose 22.7% to $0.94 in pre-market trading after jumping around 30% on Wednesday. Statera Biopharma, Inc. STAB rose 15.4% to $0.12 in pre-market trading after gaining more than 6% on Wednesday. Canoo Inc. GOEV rose 13.9% to $1.23 in pre-market trading. Canoo Director, Executive Chairman and CEO Tony Aquila acquired a total of 9,009,009 shares at an average price of $1.11. NeuroBo Pharmaceuticals, Inc. NRBO rose 9.2% to $1.78 in pre-market trading after jumping over 35% on Wednesday. Core Scientific, Inc. CORZ shares rose 8.5% to $0.16 in pre-market trading after climbing 10% on Wednesday. SuperCom Ltd. SPCB rose 7.6% to $1.97 in pre-market trading. SuperCom, on Wednesday, announced a reverse stock split. Meta Materials Inc. MMAT rose 7.6% to $1.98 in pre-market trading. Meta Materials Board of Directors approved planned completion of the spin-off of Next Bridge Hydrocarbons Inc. Exagen Inc. XGN rose 7.4% to $3.65 in pre-market trading after surging around 33% on Wednesday. Exagen recently reported better-than-expected Q3 results. Helius Medical Technologies, Inc. HSDT rose 7.4% to $0.3544 in pre-market trading after gaining over 9% on Wednesday. Helius Medical Tech recently posted a Q3 loss of $0.12 per share. Conformis, Inc CFMS rose 7.3% to $2.21 in pre-market trading after gaining around 7% on Wednesday. Rocket Lab USA, Inc. RKLB gained 6.1% to $4.67 in pre-market trading after the company announced it was selected by NASA to launch the TROPICS mission. AD Losers Kalera Public Limited Company KAL fell 18.1% to $0.1320 in pre-market trading after jumping around 77% on Wednesday. Kalera recently posted a Q3 loss of $0.05 per share. Spectrum Pharmaceuticals, Inc. SPPI shares fell 13.4% to $0.3720 in pre-market trading. Spectrum Pharmaceuticals recently posted a Q3 loss of $0.12 per share. Lufax Holding Ltd LU shares fell 11.4% to $1.55 in pre-market trading after the company posted weaker-than-expected earnings for its third quarter. Sintx Technologies, Inc. SINT shares fell 10% to $0.0960 in pre-market trading. SiNtx Technologies, said on November 17, 2022, that the company received notice from listing qualifications staff of NASDAQ for being in contravention of NASDAQ $0.10 rule. FOXO Technologies Inc. FOXO fell 7.8% to $0.5752 in pre-market trading. FOXO Technologies announced filing of Form 10-Q for the third quarter. QualTek Services Inc. QTEK shares fell 6.3% to $0.8580 in pre-market trading. The company recently reported downbeat Q3 results. Invacare Corporation IVC fell 5.1% to $0.37 in pre-market trading. Invacare recently named Geoff Purtill as President and Chief Executive Officer. Gambling.com Group Limited GAMB fell 5.1% to $9.41 in pre-market trading. The company recently posted upbeat quarterly results. 2022 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Veon Frequently Asked Questions (FAQ)

  • Where is Veon's headquarters?

    Veon's headquarters is located at Herzliya.

  • What is Veon's latest funding round?

    Veon's latest funding round is Acquired.

  • How much did Veon raise?

    Veon raised a total of $13.5M.

  • Who are the investors of Veon?

    Investors of Veon include Philips, DFJ Tamir Fishman Ventures, Sanderling Ventures and Pitango Venture Capital.

  • Who are Veon's competitors?

    Competitors of Veon include eSight, Orthoscan, Celsense, Corpora Systems, Real Imaging and 12 more.

Compare Veon to Competitors

K
Kjaya

Kjaya is a company that received a SBIR Phase I grant for a project entitled: Semi-Autonomous Adaptive Neural and Genetic Segmentation of Medical Images. Their Phase I project will implement a physician-assisted, real-time adaptive system for the segmentation of anatomical structures in 3D medical image data. Medical image segmentation seeks to change the representation of an anatomical structure, making it more easily analyzed. Because of the extreme variability of these structures in biological systems, current idiosyncratic manual methods currently in use are tedious, time consuming, and error prone. Image segmentation cannot in general be programmatically solved. The proposed system is a Neural Network (NN) based adaptation of the individual data using parallel Graphics Processing Units (GPUs) and coupled with a Genetic Algorithm (GA) based adaptation across GPU cores. The system will build a diagnostically useful segmentation of the anatomical feature within seconds from an area of interest outlined by a physician using a Computed Tomography (CT) or Magnetic Resonance Imaging (MRI) scan. Fast growth in medical imaging overwhelms available diagnosticians. An intuitive and inexpensive system to quickly and accurately deliver diagnostic relevant segmentation of medical images offers tremendous commercial value. Currently, each scan requires approximately 50 minutes of manual preparation. The diagnosis and treatment of an estimated 20 percent of diseases benefit from medical imaging. Newer scanning technologies have increased in resolution, but such techniques have not made segmenting easier or faster. The proposed method will enable more diagnostics to be done with the quality controlled directly by physicians.

N
Nanocrystal Imaging

Nanocrystal Imaging Corporation (NIC) was founded in October 1997 to exploit some of NCT's discoveries in the creation of high quality digital x-ray images. This has been a major objective of the medical imaging industry during the last decade. Digital x-ray imaging systems developed to date by other manufacturers do not produce images with sufficiently high resolution and contrast. After a 4-year effort, NIC has developed patented products and processes which can provide a reliable platform to achieve high quality digital x-ray imaging. The first of NIC's products for commercial use is addressed to the dental imaging market, and will be marketed by mid 2003. Products addressing other market will be available in successive years. in the creation of nano-sized luminescent particles with light output equivalent to that of commercial phosphors 1000 times larger

S
Swissray International

Swissray has been recognized as the industry's true pioneer in the design, manufacture and marketing of direct digital Radiography ddR technology. Delivering high quality radiographic images in just seconds, Swissray's single detector technology aims to improve overall productivity, and lowers the cost of general radiography in comparison to conventional or computed radiography.

Q
QuantomiX

QuantomiX develops products for rapid, high resolution imaging of wet samples.The company was founded in 2001 to commercialize its technology which, for a time, aims to enable direct imaging of fully hydrated samples in an electron microscope.With the Quantomix QXTM capsule product line, wet samples, including cells and tissues, can now be examined without any of the conventional treatments such as drying, deep freezing and sectioning. This opens the way to a better understanding of biomedical processes, to improved patient care, and to more effective pharmaceutical research.The QXTM capsules, that fit any Scanning Electron Microscope (SEM), close the resolution gap between conventional electron microscopy and light microscopy. They offer the convenient sample preparation of light microscopy.

G
Gendex Corporation

Engages in the research and development, production and distribution of imaging equipment for the dental market. Gendex offers radiology and imaging products, including panoramic x-ray, intraoral x-ray, digital imaging, cameras and software.

S
Seno Medical Instruments

Seno Medical was formed to commercialize a new modality in cancer screening and diagnosis: laser opto-acoustic imaging. Unlike most screening techniques, which rely on anatomical imaging, Seno's goal is to bring functional imaging that can detect angiogenesis to the marketplace. Products for use with humans, focusing initially on breast cancer, are also in development for subsequent testing. Seno's patented technology integrates the use of lasers and acoustics to determine the presence of angiogenesis - the growth of blood vessels and higher blood volume that always surrounds a tumor. Per the company, unlike anatomical imaging techniques, such as mammography, laser opto-acoustic imaging can detect breast cancer, for example, at its earliest clinically stage (2 mm. versus 10 mm. with mammography) without patient discomfort or exposure to harmful x-ray.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.